Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group

Figure 2

Urinary suPAR/creatinine levels in patients and controls. Scatter plot showing urinary suPAR/creatinine levels in: Healthy = healthy donors, CP = chronic pancreatitis, PDAC = pancreatic ductal adenocarcinoma. Bars indicate median values. Post-hoc comparisons (Mann-Whitney test) between clinical groups are indicated in the upper bars.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us